Unicharm (8113) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
7 Nov, 2025Executive summary
Consolidated net sales for the first nine months of FY2025 were ¥694,225 million, down 3.9% year-over-year, with core operating income at ¥86,649 million, down 16.4% year-over-year, reflecting a reaction to the previous year's record performance and strategic investments in Asia.
Profit attributable to owners of parent increased by 2.0% year-over-year to ¥60,716 million, supported by improved net financial and insurance benefit income.
Overseas markets faced challenges from economic uncertainty, increased price competition, and reputational issues in China, while Middle East and North America showed strong demand.
In Japan, steady demand for daily necessities and product innovation supported stable performance.
Strategic investments in Asia began to yield positive results in the third quarter, with revenue and profit growth in the region from July to September.
Financial highlights
Net sales: ¥694,225 million (down 3.9% YoY); core operating income: ¥86,649 million (down 16.4% YoY); EBITDA: ¥128.9 billion (down 4.8% YoY).
Profit attributable to owners of parent: ¥60,716 million (up 2.0% YoY); base EPS: ¥34.68 (up 2.8% YoY), reflecting a 3-for-1 stock split.
Gross profit for the period was ¥271,553 million, down from ¥284,642 million year-over-year.
Gross profit margin improved by 0.6 percentage points in Q3, despite a 0.3 point deterioration for the nine-month period.
Exchange rate fluctuations reduced sales by ¥11.9 billion and core operating income by ¥0.5 billion.
Outlook and guidance
FY2025 full-year forecast: net sales ¥974,000 million (up 4.0% YoY), core operating income ¥120,000 million (down 13.3% YoY), profit attributable to owners of parent ¥85,100 million (down 5.6%), and basic EPS ¥48.91.
Q4 is progressing as planned, with high growth in Japan and North America and gradual recovery in China and Thailand.
Continued focus on e-commerce and new product launches in Asia.
No changes to the previously announced forecast.
Latest events from Unicharm
- Profits fell in FY2025, but FY2026 forecasts strong recovery and higher dividends.8113
Q4 202512 Feb 2026 - Sales and profits fell, but resilient regions and cost controls support a recovery outlook.8113
Q2 20255 Aug 2025 - Record sales and profit growth continue, with strong overseas and segment performance.8113
Q2 202413 Jun 2025 - Record sales and profit growth, with strong personal and pet care and rising dividends.8113
Q3 202413 Jun 2025 - Net profit jumped in Q1 FY2025 despite lower sales, aided by insurance proceeds.8113
Q1 20256 Jun 2025 - Record sales and profit growth, with a stock split and strong FY2025 outlook.8113
Q4 20245 Jun 2025